Literature DB >> 31558259

Ischemia on PET MPI May Identify Patients With Improvement in Angina and Health Status Post-Revascularization.

Krishna K Patel, John A Spertus, Suzanne V Arnold, Paul S Chan, Kevin F Kennedy, Philip G Jones, Firas Al Badarin, James A Case, Staci Courter, A Iain McGhie, Timothy M Bateman.   

Abstract

Entities:  

Year:  2019        PMID： 31558259      PMCID： PMC7061442          DOI： 10.1016/j.jacc.2019.06.074

Source DB:  PubMed          Journal:  J Am Coll Cardiol        ISSN： 0735-1097            Impact factor:   24.094


× No keyword cloud information.
  1 in total

1.  Impact of ischaemia and scar on the therapeutic benefit derived from myocardial revascularization vs. medical therapy among patients undergoing stress-rest myocardial perfusion scintigraphy.

Authors:  Rory Hachamovitch; Alan Rozanski; Leslee J Shaw; Gregg W Stone; Louise E J Thomson; John D Friedman; Sean W Hayes; Ishac Cohen; Guido Germano; Daniel S Berman
Journal:  Eur Heart J       Date:  2011-01-21       Impact factor: 29.983
  1 in total
  3 in total

1.  Impact of the ISCHEMIA Trial on Stress Nuclear Myocardial Perfusion Imaging.

Authors:  Venkatesh L Murthy; Timothy M Bateman; Wengen Chen; Saurabh Malhotra; Edward J Miller; Terrence D Ruddy; Vasken Dilsizian
Journal:  J Nucl Med       Date:  2020-07       Impact factor: 10.057

Review 2.  Complete versus incomplete coronary revascularization: definitions, assessment and outcomes.

Authors:  Prakriti Gaba; Bernard J Gersh; Ziad A Ali; Jeffrey W Moses; Gregg W Stone
Journal:  Nat Rev Cardiol       Date:  2020-10-16       Impact factor: 32.419

3.  Prognostic Relationship Between Coronary Artery Calcium Score, Perfusion Defects, and Myocardial Blood Flow Reserve in Patients With Suspected Coronary Artery Disease.

Authors:  Krishna K Patel; Poghni A Peri-Okonny; Raed Qarajeh; Femina S Patel; Brett W Sperry; A Iain McGhie; Randall C Thompson; Kevin F Kennedy; Paul S Chan; John A Spertus; Timothy M Bateman
Journal:  Circ Cardiovasc Imaging       Date:  2022-04-13       Impact factor: 7.792
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.